Meinian Onehealth Healthcare Holdings Co., Ltd. (SHE:002044)
China flag China · Delayed Price · Currency is CNY
6.17
-0.03 (-0.48%)
May 8, 2026, 3:04 PM CST

SHE:002044 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
10,12610,29610,65710,8708,6029,200
Other Revenue
63.2863.2845.2223.2114.1815.96
10,18910,36010,70210,8948,6169,216
Revenue Growth (YoY)
-4.37%-3.20%-1.76%26.44%-6.51%17.43%
Cost of Revenue
5,9206,0756,1236,2325,6495,580
Gross Profit
4,2694,2854,5794,6612,9673,636
Selling, General & Admin
3,1503,2013,4303,3952,8632,819
Research & Development
51.852.6954.9662.6556.3560.22
Other Operating Expenses
2.523.594.963.732.61.76
Operating Expenses
3,3313,3873,6263,4463,0742,962
Operating Income
938.25897.13952.391,216-106.83674.33
Interest Expense
-297.78-304.38-319.37-303.68-291.43-353.66
Interest & Investment Income
44.1145.9925.1121.6314.0688.04
Currency Exchange Gain (Loss)
0.010.010.03-0.02-0.332.17
Other Non Operating Income (Expenses)
-17.96-17.76-20.21-33.94-24.98-32.81
EBT Excluding Unusual Items
666.64620.99637.95899.55-409.52378.07
Impairment of Goodwill
-40.11-40.11-6.71-41.86--
Gain (Loss) on Sale of Investments
10.8917.63-29.371.785.84-0.57
Gain (Loss) on Sale of Assets
-8.28-10.2-8.49-6.89-8.16-6.17
Asset Writedown
-34.58-34.58-18.24-26.96-66.84-28.27
Legal Settlements
------7.92
Other Unusual Items
3.733.7317.3722.4327.9629.61
Pretax Income
598.28557.45592.52848.06-450.72364.75
Income Tax Expense
198.88186.87183.53179.2350.86205.57
Earnings From Continuing Operations
399.4370.58408.99668.82-501.58159.19
Minority Interest in Earnings
-93.77-85.26-126.75-163.2-57.44-97.61
Net Income
305.63285.33282.24505.62-559.0261.58
Net Income to Common
305.63285.33282.24505.62-559.0261.58
Net Income Growth
4.13%1.09%-44.18%---88.83%
Shares Outstanding (Basic)
4,0044,0764,0323,8893,9933,079
Shares Outstanding (Diluted)
4,0044,0764,0323,8893,9933,079
Shares Change (YoY)
0.30%1.09%3.67%-2.60%29.69%-21.77%
EPS (Basic)
0.080.070.070.13-0.140.02
EPS (Diluted)
0.080.070.070.13-0.140.02
EPS Growth
3.82%--46.15%---85.71%
Free Cash Flow
1,3601,3811,2161,6161,1281,624
Free Cash Flow Per Share
0.340.340.300.410.280.53
Dividend Per Share
0.0090.0090.0130.019--
Dividend Growth
-33.33%-33.33%-28.95%---
Gross Margin
41.90%41.36%42.78%42.79%34.44%39.46%
Operating Margin
9.21%8.66%8.90%11.16%-1.24%7.32%
Profit Margin
3.00%2.75%2.64%4.64%-6.49%0.67%
Free Cash Flow Margin
13.35%13.33%11.36%14.83%13.09%17.62%
EBITDA
1,3691,3381,4301,672337.891,094
EBITDA Margin
13.44%12.91%13.37%15.35%3.92%11.87%
D&A For EBITDA
431.02440.41478456.19444.73419.94
EBIT
938.25897.13952.391,216-106.83674.33
EBIT Margin
9.21%8.66%8.90%11.16%-1.24%7.32%
Effective Tax Rate
33.24%33.52%30.97%21.13%-56.36%
Revenue as Reported
10,18910,36010,70210,8948,6169,216
Advertising Expenses
-79.41100.4972.5367.8194.96
Source: S&P Global Market Intelligence. Standard template. Financial Sources.